Staffaroni, Adam M. http://orcid.org/0000-0002-3903-9805
Quintana, Melanie http://orcid.org/0000-0002-1763-2704
Wendelberger, Barbara http://orcid.org/0000-0003-4426-9602
Heuer, Hilary W.
Russell, Lucy L. http://orcid.org/0000-0001-5023-5893
Cobigo, Yann http://orcid.org/0000-0002-0354-4092
Wolf, Amy
Goh, Sheng-Yang Matt
Petrucelli, Leonard
Gendron, Tania F. http://orcid.org/0000-0002-7335-2627
Heller, Carolin http://orcid.org/0000-0002-1934-6162
Clark, Annie L.
Taylor, Jack Carson http://orcid.org/0000-0002-6431-9956
Wise, Amy
Ong, Elise
Forsberg, Leah
Brushaber, Danielle
Rojas, Julio C.
VandeVrede, Lawren http://orcid.org/0000-0002-8304-6711
Ljubenkov, Peter
Kramer, Joel
Casaletto, Kaitlin B.
Appleby, Brian
Bordelon, Yvette
Botha, Hugo http://orcid.org/0000-0003-4390-685X
Dickerson, Bradford C.
Domoto-Reilly, Kimiko http://orcid.org/0000-0002-7396-1633
Fields, Julie A.
Foroud, Tatiana http://orcid.org/0000-0002-5549-2212
Gavrilova, Ralitza
Geschwind, Daniel http://orcid.org/0000-0003-2896-3450
Ghoshal, Nupur http://orcid.org/0000-0002-6680-6731
Goldman, Jill
Graff-Radford, Jonathon
Graff-Radford, Neill
Grossman, Murray
Hall, Matthew G. H.
Hsiung, Ging-Yuek http://orcid.org/0000-0002-8017-0856
Huey, Edward D.
Irwin, David
Jones, David T. http://orcid.org/0000-0002-4807-9833
Kantarci, Kejal
Kaufer, Daniel
Knopman, David http://orcid.org/0000-0002-6544-066X
Kremers, Walter
Lago, Argentina Lario
Lapid, Maria I. http://orcid.org/0000-0002-1163-5584
Litvan, Irene http://orcid.org/0000-0002-3485-3445
Lucente, Diane
Mackenzie, Ian R.
Mendez, Mario F. http://orcid.org/0000-0001-6441-7989
Mester, Carly
Miller, Bruce L.
Onyike, Chiadi U.
Rademakers, Rosa http://orcid.org/0000-0002-4049-0863
Ramanan, Vijay K. http://orcid.org/0000-0001-6591-8734
Ramos, Eliana Marisa
Rao, Meghana
Rascovsky, Katya
Rankin, Katherine P.
Roberson, Erik D. http://orcid.org/0000-0002-1810-9763
Savica, Rodolfo
Tartaglia, M. Carmela http://orcid.org/0000-0002-5944-8497
Weintraub, Sandra
Wong, Bonnie
Cash, David M. http://orcid.org/0000-0001-7833-616X
Bouzigues, Arabella http://orcid.org/0000-0002-0267-8590
Swift, Imogen J.
Peakman, Georgia http://orcid.org/0000-0002-3319-138X
Bocchetta, Martina http://orcid.org/0000-0003-1814-5024
Todd, Emily G.
Convery, Rhian S.
Rowe, James B. http://orcid.org/0000-0001-7216-8679
Borroni, Barbara
Galimberti, Daniela http://orcid.org/0000-0002-9284-5953
Tiraboschi, Pietro
Masellis, Mario
Finger, Elizabeth
van Swieten, John C.
Seelaar, Harro http://orcid.org/0000-0003-1989-7527
Jiskoot, Lize C.
Sorbi, Sandro http://orcid.org/0000-0002-0380-6670
Butler, Chris R.
Graff, Caroline
Gerhard, Alexander http://orcid.org/0000-0002-8071-6062
Langheinrich, Tobias http://orcid.org/0000-0002-4714-8657
Laforce, Robert http://orcid.org/0000-0002-2031-490X
Sanchez-Valle, Raquel http://orcid.org/0000-0001-7750-896X
de Mendonça, Alexandre
Moreno, Fermin
Synofzik, Matthis
Vandenberghe, Rik
Ducharme, Simon
Le Ber, Isabelle
Levin, Johannes
Danek, Adrian http://orcid.org/0000-0001-8857-5383
Otto, Markus
Pasquier, Florence http://orcid.org/0000-0001-9880-9788
Santana, Isabel
Kornak, John
Boeve, Bradley F. http://orcid.org/0000-0002-4153-8187
Rosen, Howard J.
Rohrer, Jonathan D.
Boxer, Adam. L. http://orcid.org/0000-0002-1215-5064
Apostolova, Liana
Barmada, Sami
Boeve, Bradley http://orcid.org/0000-0002-4153-8187
Boxer, Adam L. http://orcid.org/0000-0002-1215-5064
Bozoki, Andrea
Clark, David
Coppola, Giovanni
Darby, Ryan
Dickson, Dennis
Faber, Kelley
Fagan, Anne
Galasko, Douglas R.
Grant, Ian M.
Huang, Eric
Kerwin, Diana
Lapid, Maria http://orcid.org/0000-0002-1163-5584
Lee, Suzee
Leger, Gabriel
Masdeux, Joseph C.
McGinnis, Scott
Mendez, Mario http://orcid.org/0000-0001-6441-7989
Onyike, Chiadi
Pascual, M. Belen
Pressman, Peter
Rademakers, Rosa http://orcid.org/0000-0002-4049-0863
Ramanan, Vijay http://orcid.org/0000-0001-6591-8734
Ritter, Aaron
Seeley, William W.
Syrjanen, Jeremy
Taylor, Jack C. http://orcid.org/0000-0002-6431-9956
Weintraub, Sandra
Esteve, Aitana Sogorb
Nelson, Annabel
Greaves, Caroline V.
Thomas, David L.
Benotmane, Hanya
Zetterberg, Henrik
Nicholas, Jennifer
Samra, Kiran
Shafei, Rachelle
Timberlake, Carolyn
Cope, Thomas
Rittman, Timothy
Benussi, Alberto
Premi, Enrico
Gasparotti, Roberto
Archetti, Silvana
Gazzina, Stefano
Cantoni, Valentina
Arighi, Andrea
Fenoglio, Chiara
Scarpini, Elio
Fumagalli, Giorgio
Borracci, Vittoria
Rossi, Giacomina
Giaccone, Giorgio
Di Fede, Giuseppe
Caroppo, Paola
Prioni, Sara
Redaelli, Veronica
Tang-Wai, David
Rogaeva, Ekaterina
Castelo-Branco, Miguel
Freedman, Morris
Keren, Ron
Black, Sandra
Mitchell, Sara
Shoesmith, Christen
Bartha, Robart
Poos, Jackie
Papma, Janne M.
Giannini, Lucia
van Minkelen, Rick
Pijnenburg, Yolande
Nacmias, Benedetta
Ferrari, Camilla
Polito, Cristina
Lombardi, Gemma
Bessi, Valentina
Veldsman, Michele
Andersson, Christin
Thonberg, Hakan
Öijerstedt, Linn
Jelic, Vesna
Thompson, Paul
Lladó, Albert
Antonell, Anna
Olives, Jaume
Balasa, Mircea
Bargalló, Nuria
Borrego-Ecija, Sergi
Verdelho, Ana
Maruta, Carolina
Ferreira, Catarina B.
Miltenberger, Gabriel
Simões do Couto, Frederico
Gabilondo, Alazne
Gorostidi, Ana
Villanua, Jorge
Cañada, Marta
Tainta, Mikel
Zulaica, Miren
Barandiaran, Myriam
Alves, Patricia
Bender, Benjamin
Wilke, Carlo
Graf, Lisa
Vogels, Annick
Vandenbulcke, Mathieu
Van Damme, Philip
Bruffaerts, Rose
Poesen, Koen
Rosa-Neto, Pedro
Gauthier, Serge
Camuzat, Agnès
Brice, Alexis
Bertrand, Anne
Funkiewiez, Aurélie
Rinaldi, Daisy
Saracino, Dario
Colliot, Olivier
Sayah, Sabrina
Prix, Catharina
Wlasich, Elisabeth
Wagemann, Olivia
Loosli, Sandra
Schönecker, Sonja
Hoegen, Tobias
Lombardi, Jolina
Anderl-Straub, Sarah
Rollin, Adeline
Kuchcinski, Gregory
Bertoux, Maxime
Lebouvier, Thibaud
Deramecourt, Vincent
Santiago, Beatriz
Duro, Diana
Leitão, Maria João
Almeida, Maria Rosario
Tábuas-Pereira, Miguel
Afonso, Sónia
,
,
,
Article History
Received: 11 December 2021
Accepted: 8 July 2022
First Online: 22 September 2022
Competing interests
: B.A. receives research support from the Centers for Disease Control and Prevention, the National Institutes of Health (NIH), Ionis, Alector and the CJD Foundation. He has provided consultation to Acadia, Ionis and Sangamo. B.F.B. has served as an investigator for clinical trials sponsored by EIP Pharma, Alector and Biogen. He receives royalties from the publication of a book entitled <i>Behavioral Neurology of Dementia</i> (Cambridge Medicine, 2009, 2017). He serves on the Scientific Advisory Board of the Tau Consortium. He receives research support from the NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program and the Little Family Foundation. H.B. receives research support from the NIH. A.L.B. receives research support from the NIH, the Tau Research Consortium, the Association for Frontotemporal Degeneration, Bluefield Project to Cure Frontotemporal Dementia, Corticobasal Degeneration Solutions, the Alzheimer’s Drug Discovery Foundation and the Alzheimer’s Association. He has served as a consultant for Aeovian, AGTC, Alector, Arkuda, Arvinas, Boehringer Ingelheim, Denali, GSK, Life Edit, Humana, Oligomerix, Oscotec, Roche, TrueBinding and Wave and received research support from Biogen, Eisai and Regeneron. B.C.D. is a consultant for Acadia, Alector, Arkuda, Biogen, Denali, Eisai, Genentech, Lilly, Merck, Novartis, Takeda and Wave Lifesciences; receives royalties from Cambridge University Press, Elsevier and Oxford University Press; and receives grant funding from the NIA, the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health and the Bluefield Foundation. K.D.-R. receives research support from the NIH and serves as an investigator for a clinical trial sponsored by Lawson Health Research Institute. S.D. has participated or is currently participating in clinical trials of anti-dementia drugs sponsored by Biogen, Ionis Pharmaceuticals, Wave Life Sciences and Janssen. He has received speaking honorarium/advisory fees from Eisai, Biogen, Innodem Neurosciences and NeuroCatch and receives salary support from the Fond de Recherche du Québec – Santé. K.F. receives research support from the NIH. J.A.F. receives research support from the NIH. T.F. receives research support from the NIH. L.F. receives research support from the NIH. R.G. receives research support from the NIH. T.F.G. receives research support from the NIH. N.G. has participated or is currently participating in clinical trials of anti-dementia drugs sponsored by Bristol Myers Squibb, Eli Lilly/Avid Radiopharmaceuticals, Janssen Immunotherapy, Novartis, Pfizer, Wyeth, SNIFF (The Study of Nasal Insulin to Fight Forgetfulness) and the A4 (The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease) trial. She receives research support from Tau Consortium and the Association for Frontotemporal Dementia and is funded by the NIH. J.G. is serving as a consultant to the Novartis Alzheimer’s Prevention Advisory Board. She receives research support from the NIH, Huntington’s Disease Society of America and the New York State Department of Health (RFA 1510130358). J.G.-R. receives research support from the NIH and is on the editorial board of <i>Neurology</i>. N.G.-R. receives royalties from UpToDate and has participated in multicenter therapy studies by sponsored by Biogen, TauRx, AbbVie, Novartis and Lilly. He receives research support from the NIH. M.G. receives grant support from the NIH, Avid and Piramal; participates in clinical trials sponsored by Biogen, TauRx and Alector; serves as a consultant to Bracco and UCB; and serves on the editorial board of <i>Neurology</i>. G.-Y.H. has served as an investigator for clinical trials sponsored by AstraZeneca, Eli Lilly and Roche/Genentech. He receives research support from the Canadian Institutes of Health Research and the Alzheimer Society of British Columbia. E.D.H. receives research support from the NIH. D.I. receives support from the NIH, BrightFocus Foundation and Penn Institute on Aging. D.T.J. receives research support from the NIH and the Minnesota Partnership for Biotechnology and Medical Genomics. K.K. served on the Data Safety Monitoring Board for Takeda Global Research & Development Center and data monitoring boards of Pfizer and Janssen Alzheimer Immunotherapy and received research support from Avid Radiopharmaceuticals, Eli Lilly, the Alzheimer’s Drug Discovery Foundation and the NIH. D. Kerwin has served on an advisory board for AbbVie and as site principal investigator for studies funded by Roche/Genentech, AbbVie, Avid, Novartis, Eisai, Eli Lilly and UCSF. D. Knopman serves on the data and safety monitoring board of the DIAN-TU study; is a site principal investigator for clinical trials sponsored by Biogen, Lilly and the University of Southern California; and is funded by the NIH. J. Kornak has provided expert witness testimony for Teva Pharmaceuticals in <i>Forest Laboratories Inc. et al. v. Teva Pharmaceuticals USA, Inc</i>., case numbers 1:14-cv-00121 and 1:14-cv-00686 (D. Del. filed 31 January 2014 and 30 May 2014 regarding the drug Memantine) and for Apotex/HEC/Ezra in <i>Novartis AG et al. v. Apotex Inc</i>., case number 1:15-cv-975 (D. Del. filed 26 October 2015 regarding the drug Fingolimod). He has also given testimony on behalf of Puma Biotechnology in <i>Hsingching Hsu et al</i>, <i>vs</i>. <i>Puma Biotechnology, Inc</i>., <i>et al</i>. 2018 regarding the drug Neratinib. He receives research support from the NIH. J. Kramer receives royalties from Pearson. W.K. receives research funding from AstraZeneca, Biogen, Roche, the Department of Defense and the NIH. M.I.L. receives research support from the NIH. J.L. reports speaker fees from Bayer Vital, Biogen and Roche; consulting fees from Axon Neuroscience and Biogen; author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers; non-financial support from AbbVie; and compensation for duty as part-time chief medical officer from MODAG outside the submitted work. I.L. receives research support from the NIH (grants: 2R01AG038791-06A, U01NS100610, U01NS80818, R25NS098999, U19AG063911 -1 and 1R21NS114764-01A1), the Michael J Fox Foundation, the Parkinson Foundation, the Lewy Body Association, CurePSP, Roche, AbbVie, Biogen, Centogene. EIP Pharma, Biohaven Pharmaceuticals, Novartis, Brain Neurotherapy Bio and United Biopharma SRL - UCB. She was a member of the scientific advisory board of Lundbeck and is a scientific advisor for Amydis and Rossy Center for Progressive Supranuclear Palsy University of Toronto. She receives her salary from the University of California, San Diego and as Chief Editor of <i>Frontiers in Neurology</i>. P.L. is a site primary investigator for clinical trials by Alector, AbbVie and Woolsey. He serves as an advisor for Retrotrope. He receives research and salary support from the NIH-NIA and the Alzheimer’s Association-Part the Cloud partnership. D.L. receives research support from the NIH. I.R.M. receives research funding from the Canadian Institutes of Health Research, the Alzheimer’s Association US, the NIH and the Weston Brain Institute. M.M. reports grant funding from the Canadian Institutes of Health Research relating to this work and grants from the Canadian Institutes of Health Research, Woman’s Brain Health Initiative, Brain Canada, Ontario Brain Institute, Weston Brain Institute and Washington University outside of this submitted work. M.M. has received personal fees for serving on a scientific advisory committee for Ionis Pharmaceuticals, Alector Pharmaceuticals, Wave Life Sciences and Biogen Canada outside of this submitted work. M.M. has received royalties from Henry Stewart Talks outside of this submitted work. M.M. is a clinical trial site investigator for Roche and Alector Pharmaceuticals outside of this submitted work. S.M. has served as an investigator for clinical trials sponsored by AbbVie, Allon Therapeutics, Biogen, Bristol Myers Squibb, C2N Diagnostics, Eisai, Eli Lilly and Co., Genentech, Janssen Pharmaceuticals, Medivation, Merck, Navidea Biopharmaceuticals, Novartis, Pfizer and TauRx Therapeutics. He receives research support from the NIH. M.F.M. receives research support from the NIH. B.L.M. is Director and Internal Advisor of The Bluefield Project to Cure FTD, Co-Director and Scientific Advisor of the Tau Consortium, Co-Director of the Global Brain Health Institute, Co-Director and medical advisor for The John Douglas French Foundation, scientific advisor for The Larry L. Hillblom Foundation, Scientific Advisor for Association for Frontotemporal Degeneration, Scientific Advisor for National Institute for Health Research Cambridge Biomedical Research Centre and its subunit, the Biomedical Research Unit in Dementia, external advisor to University of Washington ADRC, Stanford University ADRC, Arizona Alzheimer’s Disease Center, Massachusetts Alzheimer Disease Research Center, and scientific advisor to The Buck Institute for Research on Aging. B.L.M. serves as Editor-in-Chief for <i>Neurocase</i>, on the editorial board of <i>ALS/FTD Journal</i> (Taylor & Francis), Section Editor for <i>Frontiers</i> and editor for <i>PLOS Medicine</i>. He receives royalties from Cambridge University Press, Guilford Publications, Johns Hopkins Press, Oxford University Press, Taylor & Francis Group, Elsevier and Up-to-Date. C.U.O. receives research funding from the NIH, Lawton Health Research Institute, National Ataxia Foundation, Alector and Transposon. He is also supported by the Robert and Nancy Hall Brain Research Fund, the Jane Tanger Black Fund for Young-Onset Dementias and a gift from Joseph Trovato. He is a consultant with Alector and Acadia Pharmaceuticals. L.P. receives research support from the NIH. M.Q. is an employee of Berry Consultants, where she serves as a consultant to numerous pharmaceutical and device companies. R.R. receives research funding from the NIH and the Bluefield Project to Cure Frontotemporal Dementia. R.R. is on the scientific advisory board of Arkuda Therapeutics and receives royalties from progranulin-related patent. She is also on the scientific advisory board of the Fondation Alzheimer. E.M.R. receives research support from the NIH. K.P.R. receives research support from the NIH and the National Science Foundation and serves on a medical advisory board for Eli Lilly. K.R. receives research support from the NIH. E.D.R. receives research support from the NIH, the Bluefield Project to Cure Frontotemporal Dementia, the Alzheimer’s Association, the BrightFocus Foundation, Biogen and Alector; has served as a consultant for AGTC and on a data and safety monitoring board for Lilly; and owns intellectual property related to tau. J.D.R. has served on a medical advisory board and had a consultancy agreement with Alector, Arkuda Therapeutics, Wave Life Sciences, Prevail Therapeutics, UCB, AC Immune, Astex Pharmaceuticals, Biogen, Takeda and Eisai. J.C.R. receives research support from the NIH and is a site principal investigator for clinical trials sponsored by Eli Lilly and Eisai. H.J.R. has received research support from Biogen Pharmaceuticals, has consulting agreements with Wave Neuroscience and Ionis Pharmaceuticals and receives research support from the NIH. J.B.R. has research grants unrelated to the current work from AstraZeneca, Janssen, Lilly and GSK via the Dementias Platform UK and has provided consultancy unrelated to the current work to Asceneuron, Astex, Curasen, UCB, SV Health, WAVE and Alzheimer Research UK. R.S.-V. receives personal fees from Wave Pharmaceuticals for attending advisory board meetings; personal fees from Roche Diagnostics, Janssen and Neuraxpharm for educational activities; and research grants to her institution from Biogen and Sage Therapeutics outside the submitted work. R.S. receives support from the NIA, the National Institute of Neurological Disorders and Stroke, the Parkinson’s Disease Foundation and Acadia Pharmaceuticals. A.M.S. received research support from the NIA/NIH, the Bluefield Project to Cure FTD and the Larry L. Hillblom Foundation. He has provided consultation to Passage Bio and Takeda. M.C.T. has served as an investigator for clinical trials sponsored by Biogen, Avanex, Green Valley, Roche/Genentech, Bristol Myers Squibb, Eli Lilly/Avid Radiopharmaceuticals and Janssen. She receives research support from the Canadian Institutes of Health Research. N.T. was employed by the Association for Frontotemporal Degeneration and is now employed by Alector. L.V.V. receives research support from the Alzheimer’s Association, the American Academy of Neurology, the American Brain Foundation and the NIH and has provided consultation for Retrotope. S.W. receives research support from the NIH. B. Wendelberger is an employee of Berry Consultants, where she serves as a consultant to numerous pharmaceutical and device companies. B. Wong receives research support from the NIH. All other authors have no competing interests.